Martin Kann

Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Cell-type-specific damage scores reveal kidney and liver disease trajectories in single-cell and spatial transcriptomics.

Cell-type-specific damage scores reveal kidney and liver disease trajectories in single-cell and spatial transcriptomics.

Journal: Cell genomics

Published: February 20, 2026

Transcriptional Regulators YAP and TAZ Have Distinct Abilities to Compensate for One Another in Podocytes.

Transcriptional Regulators YAP and TAZ Have Distinct Abilities to Compensate for One Another in Podocytes.

Journal: Journal of the American Society of Nephrology : JASN

Published: November 01, 2024

Gene regulatory networks in disease and ageing.

Gene regulatory networks in disease and ageing.

Journal: Nature reviews. Nephrology

Published: May 15, 2024

First experiences with machine learning predictions of accelerated declining eGFR slope of living kidney donors 3 years after donation.

First experiences with machine learning predictions of accelerated declining eGFR slope of living kidney donors 3 years after donation.

Journal: Journal of nephrology

Published: February 06, 2024

Five-year single-center analysis of cytomegalovirus viremia in kidney transplant recipients and possible implication for novel prophylactic therapy approaches.

Five-year single-center analysis of cytomegalovirus viremia in kidney transplant recipients and possible implication for novel prophylactic therapy approaches.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: August 31, 2023

Loss of genome maintenance is linked to mTOR complex 1 signaling and accelerates podocyte damage.

Loss of genome maintenance is linked to mTOR complex 1 signaling and accelerates podocyte damage.

Journal: JCI insight

Published: May 25, 2023

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 01, 2022

Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients.

Combined Therapy with Intravenous Immunoglobulins, Letermovir and (Val-)Ganciclovir in Complicated Courses of CMV-Infection in Transplant Recipients.

Journal: Microorganisms

Published: July 15, 2021

Update 2021: COVID-19 from the perspective of nephrology

Update 2021: COVID-19 from the perspective of nephrology

Journal: Deutsche medizinische Wochenschrift (1946)

Published: July 13, 2021

First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy.

First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancy.

Journal: British journal of haematology

Published: July 07, 2021

CALINCA-A Novel Pipeline for the Identification of lncRNAs in Podocyte Disease.

CALINCA-A Novel Pipeline for the Identification of lncRNAs in Podocyte Disease.

Journal: Cells

Published: February 24, 2021

Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation.

Monitoring of hepatitis E virus RNA during treatment for chronic hepatitis E virus infection after renal transplantation.

Journal: Immunity, inflammation and disease

Published: December 03, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026